Evidence map›Paper›PMID 34184126›Full record

ArticlePsychopharmacology2021

RGS14 modulates locomotor behavior and ERK signaling induced by environmental novelty and cocaine within discrete limbic structures.

Stephanie L Foster, Daniel J Lustberg, Nicholas H Harbin, Sara N Bramlett, John R Hepler, David Weinshenker

Open access · greenAbstract read
In one paragraph

Article in Psychopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. RGS14 Regulation of Post-Synaptic Signaling and Spine Plasticity in Brain.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Stephanie L Foster *, Department of Human Genetics, Emory University School of Medicine, 615 Michael St., Whitehead 301, Atlanta, GA, 30322, USA.
Daniel J Lustberg *, Department of Human Genetics, Emory University School of Medicine, 615 Michael St., Whitehead 301, Atlanta, GA, 30322, USA.
Nicholas H HarbinDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, 1510 Clifton Rd, Atlanta, GA, 30322, USA.
Sara N BramlettDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, 1510 Clifton Rd, Atlanta, GA, 30322, USA.
John R HeplerDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, 1510 Clifton Rd, Atlanta, GA, 30322, USA. jhepler@emory.edu.
David Weinshenker, Department of Human Genetics, Emory University School of Medicine, 615 Michael St., Whitehead 301, Atlanta, GA, 30322, USA. dweinsh@emory.edu.
Emory University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM008169 · NIGMS · EMORY UNIVERSITY · PI GROSS, ROBERT E · 1987 to 2021
$20.3M
Structure and Function of the G-alpha-i1:RGS14:H-Ras signaling complexR01NS037112 · NINDS · EMORY UNIVERSITY · PI HEPLER, JOHN R · 1998 to 2023
$7.2M
TRAINING IN TRANSLATIONAL RESEARCH IN NEUROLOGYT32NS007480 · NINDS · EMORY UNIVERSITY · PI LEVEY, ALLAN I · 2000 to 2020
$4.5M
Mechanisms underlying selective vulnerability of locus coeruleus neurons in Alzheimer's diseaseRF1AG061175 · NIA · EMORY UNIVERSITY · PI KANG, SEONG SU, WEINSHENKER, DAVID · 2019 to 2019
$2.8M
Contribution of locus coeruleus-derived galanin to opioid reward and reinforcementR01DA049257 · NIDA · EMORY UNIVERSITY · PI WEINSHENKER, DAVID · 2020 to 2024
$2.3M
Mechanisms of cocaine hypersensitivity following chronic DBH inhibition 5R01DA038453-02 Diversity SupplementR01DA038453 · NIDA · EMORY UNIVERSITY · PI PALADINI, CARLOS ANTONIO, WEINSHENKER, DAVID · 2015 to 2019
$1.8M
Norepinephrine-dopamine interactions underlying arousalR01NS102306 · NINDS · EMORY UNIVERSITY · PI MITRANO, DARLENE A, WEINSHENKER, DAVID · 2017 to 2021
$1.8M
Defining signaling roles for RGS14 and rare human variants of RGS14 in the nuclei of hippocampal neuronsR21NS102652 · NINDS · EMORY UNIVERSITY · PI HEPLER, JOHN R · 2018 to 2019
$419k
RGS proteins as novel integrators of G protein and MAPK signalingR56NS037112 · NINDS · EMORY UNIVERSITY · PI HEPLER, JOHN R · 2009 to 2009
$374k
Effect of the Neuropeptide Galanin on Opiate Self-AdministrationF31DA044726 · NIDA · EMORY UNIVERSITY · PI FOSTER, STEPHANIE · 2018 to 2020
$150k
NIA NIH HHS AG061175NIA NIH HHS RF1 AG061175NIDA NIH HHS DA038453NIDA NIH HHS DA044726NIDA NIH HHS DA049257NIDA NIH HHS F31 DA044726NIDA NIH HHS R01 DA038453NIDA NIH HHS R01 DA049257NIGMS NIH HHS T32 GM008169NINDS NIH HHS NS 007480-20NINDS NIH HHS NS037112NINDS NIH HHS NS102306NINDS NIH HHS NS102652NINDS NIH HHS R01 NS037112NINDS NIH HHS R01 NS102306NINDS NIH HHS R21 NS102652NINDS NIH HHS T32 NS007480
6 · The paper itself

Abstract

rationaleIn rodents, exposure to novel environments or psychostimulants promotes locomotion. Indeed, locomotor reactivity to novelty strongly predicts behavioral responses to psychostimulants in animal models of addiction. RGS14 is a plasticity-restricting protein with unique functional domains that enable it to suppress ERK-dependent signaling as well as regulate G protein activity. Although recent studies show that RGS14 is expressed in multiple limbic regions implicated in psychostimulant- and novelty-induced hyperlocomotion, its function has been examined mostly in the context of hippocampal physiology and memory.

objectiveWe investigated whether RGS14 modulates novelty- and cocaine-induced locomotion (NIL and CIL, respectively) and neuronal activity.

methodsWe assessed Rgs14 knockout (RGS14 KO) mice and wild-type (WT) littermate controls using NIL and CIL behavioral tests, followed by quantification of c-fos and phosphorylated ERK (pERK) induction in limbic regions that normally express RGS14.

resultsRGS14 KO mice were less active than WT controls in the NIL test, driven by avoidance of the center of the novel environment. By contrast, RGS14 KO mice demonstrated augmented peripheral locomotion in the CIL test conducted in either a familiar or novel environment. RGS14 KO mice exhibited increased thigmotaxis, as well as greater c-fos and pERK induction in the central amygdala and dorsal hippocampus, when cocaine and novelty were paired.

conclusionsRGS14 KO mice exhibited anti-correlated locomotor responses to novelty and cocaine, but displayed increased thigmotaxis in response to either stimuli which was augmented by their combination. Our findings also suggest RGS14 may reduce neuronal activity in limbic subregions by inhibiting ERK-dependent signaling.

Indexed as

Central Nervous System StimulantsCocaineMAP Kinase Signaling SystemRGS ProteinsAnimalsHippocampusMiceMice, KnockoutProto-Oncogene Proteins c-fosCentral Nervous System StimulantsCocaineProto-Oncogene Proteins c-fosRgs14 protein, mouseRGS ProteinsCentral amygdalac-fosCocaineERKHippocampal area CA1Hippocampal area CA2Novelty-induced locomotionPsychostimulant-induced locomotionRGS14Thigmotaxis

Identifiers

PMID34184126
PMCPMC8455459
OpenAlexW3176823604

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.